1-11 of 11
Ralph S. Freedman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

2013 HIPAA Changes Provide Opportunities and Challenges for Researchers: Perspectives from a Cancer Center

Ralph S. Freedman, Scott B. Cantor, Kelly W. Merriman, Mary E. Edgerton
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (3): 533–539.
https://doi.org/10.1158/1078-0432.CCR-15-2155
Published: 31 January 2016
View article titled, 2013 HIPAA Changes Provide Opportunities and Challenges for Researchers: Perspectives from a Cancer Center
Open the PDF for 2013 HIPAA Changes Provide Opportunities and Challenges for Researchers: Perspectives from a Cancer Center in another window
Journal Articles

Is Conflict of Interest Becoming a Challenge for Institution-Based Institutional Review Boards?

Ralph S. Freedman, Ross McKinney, Jr
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (15): 4034–4039.
https://doi.org/10.1158/1078-0432.CCR-13-0543
Published: 31 July 2013
View article titled, Is Conflict of Interest Becoming a Challenge for Institution-Based Institutional Review Boards?
Open the PDF for Is Conflict of Interest Becoming a Challenge for Institution-Based Institutional Review Boards? in another window
Journal Articles

Comparative Analysis of Peritoneum and Tumor Eicosanoids and Pathways in Advanced Ovarian Cancer

Ralph S. Freedman, Ena Wang, Sonia Voiculescu, Rebecca Patenia, Roland L. Bassett, Jr., Michael Deavers, Francesco M. Marincola, Peiying Yang, Robert A. Newman
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19): 5736–5744.
https://doi.org/10.1158/1078-0432.CCR-07-0583
Published: 01 October 2007
View article titled, Comparative Analysis of Peritoneum and Tumor Eicosanoids and Pathways in Advanced Ovarian Cancer
Open the PDF for Comparative Analysis of Peritoneum and Tumor Eicosanoids and Pathways in Advanced Ovarian Cancer in another window
Journal Articles

Defective Antitumor Function of Monocyte-Derived Macrophages from Epithelial Ovarian Cancer Patients

Ilyssa O. Gordon, Ralph S. Freedman
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (5): 1515–1524.
https://doi.org/10.1158/1078-0432.CCR-05-2254
Published: 06 March 2006
View article titled, Defective Antitumor Function of Monocyte-Derived Macrophages from Epithelial Ovarian Cancer Patients
Open the PDF for Defective Antitumor Function of Monocyte-Derived Macrophages from Epithelial Ovarian Cancer Patients in another window
Journal Articles

Peritoneal and Subperitoneal Stroma May Facilitate Regional Spread of Ovarian Cancer

Ena Wang, Yvonne Ngalame, Monica C. Panelli, Hoainam Nguyen-Jackson, Michael Deavers, Peter Mueller, Wei Hu, Cherylyn A. Savary, Ryuji Kobayashi, Ralph S. Freedman, Francesco M. Marincola
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (1): 113–122.
https://doi.org/10.1158/1078-0432.113.11.1
Published: 21 January 2005
View article titled, Peritoneal and Subperitoneal Stroma May Facilitate Regional Spread of Ovarian Cancer
Open the PDF for Peritoneal and Subperitoneal Stroma May Facilitate Regional Spread of Ovarian Cancer in another window
Journal Articles

Pilot Study of Flt3 Ligand Comparing Intraperitoneal with Subcutaneous Routes on Hematologic and Immunologic Responses in Patients with Peritoneal Carcinomatosis and Mesotheliomas

Ralph S. Freedman, Saroj Vadhan-Raj, Cherie Butts, Cherylyn Savary, Bohuslav Melichar, Claire Verschraegen, John J. Kavanagh, Marshall E. Hicks, Lawrence B. Levy, Jody K. Folloder, Michael E. Garcia
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (14): 5228–5237.
Published: 12 November 2003
View article titled, Pilot Study of Flt3 Ligand Comparing Intraperitoneal with Subcutaneous Routes on Hematologic and Immunologic Responses in Patients with Peritoneal Carcinomatosis and Mesotheliomas
Open the PDF for Pilot Study of Flt3 Ligand Comparing Intraperitoneal with Subcutaneous Routes on Hematologic and Immunologic Responses in Patients with Peritoneal Carcinomatosis and Mesotheliomas in another window
Journal Articles

Establishment and Characterization of Cancer Cell Cultures and Xenografts Derived from Primary or Metastatic Mullerian Cancers

Claire F. Verschraegen, Wei Hu, Yu Du, John Mendoza, Janet Early, Michael Deavers, Ralph S. Freedman, Robert C. Bast, Jr., Andrzej P. Kudelka, John J. Kavanagh, Beppino C. Giovanella
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (2): 845–852.
Published: 01 February 2003
View article titled, Establishment and Characterization of Cancer Cell Cultures and Xenografts Derived from Primary or Metastatic Mullerian Cancers
Open the PDF for Establishment and Characterization of Cancer Cell Cultures and Xenografts Derived from Primary or Metastatic Mullerian Cancers in another window
Journal Articles

Phase I Study of Intraperitoneal Recombinant Human Interleukin 12 in Patients with Müllerian Carcinoma, Gastrointestinal Primary Malignancies, and Mesothelioma

Renato Lenzi, Michael Rosenblum, Claire Verschraegen, Andrzej P. Kudelka, John J. Kavanagh, Marshall E. Hicks, Eric A. Lang, Michael A. Nash, Lawrence B. Levy, Michael E. Garcia, Chris D. Platsoucas, James L. Abbruzzese, Ralph S. Freedman
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (12): 3686–3695.
Published: 01 December 2002
View article titled, Phase I Study of Intraperitoneal Recombinant Human Interleukin 12 in Patients with Müllerian Carcinoma, Gastrointestinal Primary Malignancies, and Mesothelioma
Open the PDF for Phase I Study of Intraperitoneal Recombinant Human Interleukin 12 in Patients with Müllerian Carcinoma, Gastrointestinal Primary Malignancies, and Mesothelioma in another window
Journal Articles

The Expression of Decorin in Human Ovarian Tumors

Michael A. Nash, Michael T. Deavers, Ralph S. Freedman
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (6): 1754–1760.
Published: 01 June 2002
View article titled, The Expression of Decorin in Human Ovarian Tumors
Open the PDF for The Expression of Decorin in Human Ovarian Tumors in another window
Journal Articles

Clinical and Biological Effects of Intraperitoneal Injections of Recombinant Interferon-γ and Recombinant Interleukin 2 with or without Tumor-infiltrating Lymphocytes in Patients with Ovarian or Peritoneal Carcinoma

Ralph S. Freedman, Andrzej P. Kudelka, John J. Kavanagh, Claire Verschraegen, Creighton L. Edwards, Micheal Nash, Lawrence Levy, Edward N. Atkinson, Hua-Zhong Zhang, Bohuslav Melichar, Rebecca Patenia, Stacie Templin, Wanza Scott, Chris D. Platsoucas
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (6): 2268–2278.
Published: 01 June 2000
View article titled, Clinical and Biological Effects of Intraperitoneal Injections of Recombinant Interferon-γ and Recombinant Interleukin 2 with or without Tumor-infiltrating Lymphocytes in Patients with Ovarian or Peritoneal Carcinoma
Open the PDF for Clinical and Biological Effects of Intraperitoneal Injections of Recombinant Interferon-γ and Recombinant Interleukin 2 with or without Tumor-infiltrating Lymphocytes in Patients with Ovarian or Peritoneal Carcinoma in another window
Journal Articles

Quantitative Analysis of Transforming Growth Factor β1 and 2 in Ovarian Carcinoma

Mary Evelyn Gordinier, Hua-Zhong Zhang, Rebecca Patenia, Lawrence B. Levy, E. Neely Atkinson, Micheal A. Nash, Ruth L. Katz, Chris D. Platsoucas, Ralph S. Freedman
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (9): 2498–2505.
Published: 01 September 1999
View article titled, Quantitative Analysis of Transforming Growth Factor β1 and 2 in Ovarian Carcinoma
Open the PDF for Quantitative Analysis of Transforming Growth Factor β1 and 2 in Ovarian Carcinoma in another window